Trabectedin Market Trends, Size, Competitive Analysis and Forecast 2021-2027
The global trabectedin market is expected to grow at a significant CAGR during the forecast period (2021-2027). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, to remain competitive in the marketplace. For instance, in November 2020, STADA Arzneimittel AG's subsidiary in the United Arab Emirates (UAE), STADA MENA DWC-LLC, announced a commercial licensing agreement for Yondelis (trabectedin) in Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, Saudi Arabia, Tunisia, United Arab Emirates (UAE), and Yemen. PharmaMar received a non-disclosed upfront payment as well as subsequent remunerations, including a regulatory milestone payment, under the terms of the license and commercialization agreement.
To Request a Sample of our Report on Trabectedin Market: https://www.omrglobal.com/request-sample/trabectedin-market
PharmaMar kept exclusive
production rights to trabectedin and sell it to STADA for clinical and
commercial use in the 15 MENA markets on an exclusive basis. This new agreement
follows PharmaMar's announcement on August 26th, 2019, regarding the agreement
reached with Janssen Products LP (Janssen), under which PharmaMar regained
commercialization rights to the product in more than 40 countries where
Yondelis has already been approved, which were previously licensed to Janssen.
Yondelis is now approved for the treatment of soft tissue sarcoma and recurrent
ovarian cancer in various MENA countries. STADA was granted exclusive rights to
sell and distribute the product in MENA nations as a result of licensing
agreement and the official transfer of marketing authorizations.In August 2020,
Valeo Pharma Inc., a Canadian specialty pharmaceutical company, announced that
it has begun commercialization of Yondelis in Canada, following the receipt of
a Notice of Compliance from Health Canada approving the transfer of the
commercial rights to Valeo. PharmaMar S.A., based in Madrid, Spain,
manufactures Yondelis (trabectedin), a new marine-derived anticancer agent. As
Yondelis is a globally recognised standard of care in the treatment of soft
tissue sarcoma, the goal of the company was to raise awareness of its benefits
and availability throughout Canada.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Product
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Johnson & Johnson
Services, Inc., and Pharma Mar, S.A., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Trabectedin Market is Available @ https://www.omrglobal.com/industry-reports/trabectedin-market
Global Trabectedin Market Report by Segment
By Product
• Purity:98%-99%
• Purity:99%
By Application
• Breast Cancer Treatment
• Ovarian Cancer Treatment
• Pediatric Sarcoma Treatment
• Others
Global Trabectedin Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment